A multicenter, randomized, double-blind, parallel-group, placebo-controlled, efficacy, safety and tolerability study of dronabinol MDI in the acute treatment of migraine headache
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2015
At a glance
- Drugs Dronabinol (Primary)
- Indications Migraine with aura; Migraine without aura
- Focus Adverse reactions; Therapeutic Use
- Sponsors Solvay Pharmaceuticals
- 08 Sep 2006 Status changed from recruiting to completed.
- 10 Dec 2005 New trial record.